|
79
|
298
|
3rjcA |
Cdk2 in complex with inhibitor l4-12 |
|
88
|
298
|
3r9nA |
Cdk2 in complex with inhibitor rc-2-21 |
|
79
|
298
|
3r8uA |
Cdk2 in complex with inhibitor rc-1-132 |
|
78
|
298
|
3rkbA |
Cdk2 in complex with inhibitor rc-2-73 |
|
82
|
298
|
3rahA |
Cdk2 in complex with inhibitor rc-2-22 |
|
77
|
298
|
3r8lA |
Cdk2 in complex with inhibitor l3-4 |
|
94
|
355
|
3rgfA |
Crystal structure of human cdk8/cycc |
|
83
|
298
|
3r83A |
Cdk2 in complex with inhibitor kvr-2-92 |
|
79
|
298
|
3r7uA |
Cdk2 in complex with inhibitor kvr-1-75 |
|
79
|
298
|
3r8mA |
Cdk2 in complex with inhibitor l3-3 |
|
77
|
298
|
3rk5A |
Cdk2 in complex with inhibitor rc-2-72 |
|
87
|
298
|
3r8vA |
Cdk2 in complex with inhibitor rc-1-135 |
|
79
|
298
|
3rk9A |
Cdk2 in complex with inhibitor rc-2-74 |
|
78
|
298
|
3rakA |
Cdk2 in complex with inhibitor rc-2-32 |
|
76
|
298
|
3r8zA |
Cdk2 in complex with inhibitor rc-1-136 |
|
80
|
298
|
3r7vA |
Cdk2 in complex with inhibitor kvr-1-9 |
|
80
|
298
|
3r9dA |
Cdk2 in complex with inhibitor rc-2-135 |
|
79
|
298
|
3r7eA |
Cdk2 in complex with inhibitor kvr-1-67 |
|
83
|
298
|
3raiA |
Cdk2 in complex with inhibitor kvr-1-160 |
|
81
|
298
|
3r8pA |
Cdk2 in complex with inhibitor nsk-mc1-6 |
|
79
|
298
|
3rk7A |
Cdk2 in complex with inhibitor rc-2-71 |
|
83
|
298
|
3r7yA |
Cdk2 in complex with inhibitor kvr-2-88 |
|
83
|
298
|
2iw8A |
Structure of human thr160-phospho cdk2-cyclin a f82h-l83v-h84d mutant with an o6-cyclohexylmethylguanine inhibitor |
|
108
|
365
|
5xqxA |
Human cdk8-cycc in complex with compound 4: n-methyl-4-(4-pyridyl)-1h-pyrrole-2-carboxamide |
|
86
|
298
|
2iw9A |
Structure of human thr160-phospho cdk2-cyclin a complexed with a bisanilinopyrimidine inhibitor |
|
55
|
274
|
5uq3A |
Crystal structure of human cdk2-spy1-p27 ternary complex |
|
73
|
296
|
5uq2A |
Crystal structure of human cdk2-spy1 complex |
|
70
|
294
|
5uq1A |
Crystal structure of human cdk2-spy1 complex |
|
84
|
300
|
5osmA |
Cdk2(f80c, c177a) with covalent adduct at c80 |
|
82
|
295
|
5osjA |
Cdk2(wt) with covalent adduct at c177 |
|
79
|
295
|
5oo1A |
Cdk2(f80c, c177a) covalent adduct with c37 at f80c |
|
84
|
295
|
5oo0A |
Cdk2(wt) covalent adduct with d28 at c177 |
|
83
|
293
|
5oo3A |
Cdk2(f80c, c177a) with covalent ligand at f80c |
|
108
|
363
|
5ceiA |
Crystal structure of cdk8:cyclin c complex with compound 22 |
|
81
|
296
|
5nevA |
Cdk2/cyclin a in complex with compound 73 |
|
88
|
325
|
5acbC |
Crystal structure of the human cdk12-cyclink complex |
|
94
|
361
|
5hvyA |
Cdk8/cycc in complex with compound 20 |
|
103
|
362
|
5hbeA |
Cdk8-cycc in complex with 8-[3-chloro-5-(1-methyl-2,2-dioxo-2, 3-dihydro-1h-2l6-benzo[c]isothiazol-5-yl)-pyridin- 4-yl]-1-oxa-3,8-diaza-spiro[4.5]decan-2-one |
|
98
|
363
|
5hbhA |
Cdk8-cycc in complex with 5-{5-chloro-4-[1-(2-methoxy-ethyl)-1,8-diaza-spiro[4.5]dec-8-yl]-pyridin-3-yl}-1-methyl-1,3-dihydro-benzo[c]isothiazole 2,2-dioxide |
|
97
|
362
|
5hnbA |
Cdk8-cycc in complex with [6-hydroxy-3-(3-methyl-benzyl)-1h-indazol-5-yl]-((s)-3-hydroxy-pyrrolidin-1-yl)-methanone |
|
75
|
295
|
5fp5A |
Structure of cyclin-dependent kinase 2 with small-molecule ligand 4- fluorobenzoic acid (at222) in an alternate binding site. |
|
98
|
313
|
5g6vA |
Crystal structure of the pctaire1 kinase in complex with inhibitor |
|
53
|
209
|
5fwpK |
Atomic cryoem structure of hsp90-cdc37-cdk4 complex |
|
69
|
291
|
5fwlK |
Atomic cryoem structure of hsp90-cdc37-cdk4 complex |
|
71
|
291
|
5fwmK |
Atomic cryoem structure of hsp90-cdc37-cdk4 complex |
|
52
|
209
|
5fwkK |
Atomic cryoem structure of hsp90-cdc37-cdk4 complex |
|
76
|
294
|
5fp6A |
Structure of cyclin-dependent kinase 2 with small-molecule ligand 3-(4,7-dichloro-1h-indol-3-yl)prop-2-yn-1-ol (at17833) in an alternate binding site. |
|
102
|
362
|
5fgkA |
Cdk8-cycc in complex with 8-[3-(3-amino-1h-indazol-6-yl)-5-chloro- pyridine-4-yl]-2,8-diaza-spiro[4.5]decan-1-one |
|
76
|
298
|
5anoA |
Crystal structure of cdk2 processed with the crystaldirect automated mounting and cryo-cooling technology |
|
96
|
331
|
5efqA |
Crystal structure of human cdk13/cyclin k in complex with adp-aluminum fluoride |
